First patient enters real-world study of Pepaxti in Spain
May 20, 2025 – Oncopeptides has enrolled the first patient in its new real-world evidence study of Pepaxti in Spain. The LAGOON study will provide new insights into how the medicine performs in clinical practice.
Oncopeptalks – Q1 and COMy
May 16, 2025 – In the latest episode of Oncopeptalks, David and Sofia discuss the key takeaways from the first quarter, Oncopeptides recent symposium at the COMy congress and what to look forward to in Q2.